Please login to the form below

Not currently logged in
Email:
Password:

INC Research to merge with InVentiv Health

Combined will be second-largest outsourcing provider after QuintilesIMS

INC researchContract research organisation INC Research and commercial services firm InVentiv Health are to combine to create the second largest biopharmaceutical outsourcing provider.

The deal, which is expected to close during the second half of 2017 and values the new at around $7.4bn, comes seven months after the $18bn merger of Quintiles and IMS Health.

The latest service sector megadeal will see INC Research shareholders hold 53% to InVentiv’s 47%.

Once completed INC Research’s chief executive officer Alastair Macdonald will hold the same role in the newly-combined firm, with inVentiv Health’s CEO Michael Bell serving as its executive chairman.

Macdonald said: “Through this strategic combination we are bringing together two of the most innovative and respected players in the field to create a leading global biopharma solutions organisation with a full suite of clinical and commercial solutions to address the needs of biopharmaceutical companies, patients, physicians and payers.”

The new merger intends to create more effective clinical studies, deepen therapeutic expertise in areas such as cardiovascular, metabolic and respiratory diseases, improve access to data assets and partner with biopharmaceutical companies.

Bell said: “The new company is purpose-built to address market realities where clinical and commercial must work together sharing expertise, data and insights to improve clinical performance.

“We believe this merger has significant client advantages as it deepens our scale, scope and therapeutic expertise.”

The organisation will be headquartered in North Carolina, US operating worldwide and the companies will each contribute five directors totalling a board of 10 directors.

Article by
Gemma Jones

11th May 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics